Aptinyx Inc. (APTX): Price and Financial Metrics
APTX Price/Volume Stats
| Current price | $0.10 | 52-week high | $0.72 |
| Prev. close | $0.09 | 52-week low | $0.01 |
| Day low | $0.09 | Volume | 231,100 |
| Day high | $0.10 | Avg. volume | 1,317,051 |
| 50-day MA | $0.07 | Dividend yield | N/A |
| 200-day MA | $0.08 | Market Cap | 6.50M |
APTX Stock Price Chart Interactive Chart >
Aptinyx Inc. (APTX) Company Bio
Aptinyx Inc. develops therapeutics for neurological disorders. The company is focused on the development of drugs that interact with the NMDA receptor, and the company says it will use the funds to advance drugs for chronic pain, post-traumatic stress disorder (PTSD) and cognitive impairment in Parkinson’s disease. The company was founded in 2015 and is based in Evantson, Illinois.
APTX Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
APTX Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | -76.13% |
| 5-year | -97.17% |
| YTD | N/A |
| 2024 | 0.00% |
| 2023 | -66.35% |
| 2022 | -89.31% |
| 2021 | -22.83% |
| 2020 | 1.17% |